Human platelet aggregation and degranulation is induced in vitro by L-thyroxine, but not by 3,5,3g2-triiodo-L-thyronine or diiodothyropropionic acid (DITPA)

Clinical and Applied Thrombosis/Hemostasis

Volumn 16, Issue 3, 2010, Pages 288-293

  Mousa, Shaymaa S ^a   Davis, Faith B ^b   Davis, Paul J ^a,b,c   Mousa, Shaker A ^a  

^a ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^b ORDWAY RESEARCH INSTITUTE   (United States)

^c ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Collagen; DITPA; GC 1; Integrin v 3; L T3; L T4; Platelet activation; Platelet aggregation; Platelet ATP secretion; Thyroxine

Indexed keywords

ADENOSINE TRIPHOSPHATE; BLOCKING AGENT; CELL SURFACE RECEPTOR; COLLAGEN; DIIODOTHYROPROPIONIC ACID; IODOTHYRONINE; LEVOTHYROXINE; LIOTHYRONINE; PHOSPHOLIPID; TETRAIODOTHYROACETIC ACID; THYROID HORMONE DERIVATIVE; THYROID HORMONE RECEPTOR; THYROXINE; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR; XT 199;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; DEGRANULATION; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MICROENVIRONMENT; NORMAL HUMAN; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTE MEMBRANE;

ACETIC ACIDS; ADENOSINE TRIPHOSPHATE; ADOLESCENT; BLOOD PLATELETS; COLLAGEN; CYTOPLASMIC GRANULES; DIIODOTHYRONINES; FEMALE; HUMANS; IMIDAZOLES; MALE; PHENOLS; PLATELET ACTIVATION; PLATELET AGGREGATION; PROPIONIC ACIDS; RECEPTORS, THYROID HORMONE; SUBSTRATE SPECIFICITY; THYROXINE; TRIIODOTHYRONINE; YOUNG ADULT;

EID: 77953632667     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029609348315     Document Type: Article

References (28)

1. Mezosi E., Szabo J., Nagy EV, et al. Nongenomic effect of thyroid hormone on free-radical production in human polymorphonuclear leukocytes. J Endocrinol. 2005 ; 185 (1). 121-129.
2. Marino F., Guasti L., Cosentino M., et al. Thyroid hormone and thyrotropin regulate intracellular free calcium concentrations in human polymorphonuclear leukocytes: in vivo and in vitro studies. Int J Immunopathol Pharmacol. 2006 ; 19 (1). 149-160.
3. Davis FB, Cody V., Davis PJ, Borzynski LJ, Blas SD Stimulation by thyroid hormone analogus of red blood cell Ca2+-ATPase activity in vitro. Correlations between hormone structure and biological activity in a human cell system. J Biol Chem. 1983 ; 258 (20). 12373-12377.
4. Mylotte KM, Cody V., Davis PJ, Davis FB, Blas SD, Schoenl M. Milrinone and thyroid hormone stimulate myocardial membrane Ca2+-ATPase activity and share structural homologies. Proc Natl Acad Sci U S A. 1985 ; 82 (23). 7974-7978.
5. Masaki H., Nishikawa M., Urakami M., et al. 3,3g2,5g2-Triiodothyronine inhibits collagen-induced human platelet aggregation. J Clin Endocrinol Metab. 1992 ; 75 (3). 721-725.
6. Mamiya S., Hagiwara M., Inoue S., Hidaka H. Thyroid hormones inhibit platelet function and myosin light chain kinase. J Biol Chem. 1989 ; 264 (15). 8575-8579.
7. Akinci B., Comlekci A., Yener S., et al. The alteration of serum soluble CD40 ligand levels in overt and subclinical hypothyroidism. Hormones. 2007 ; 6 (4). 327-333.
8. Bruno AN, Pochmann D., Ricachenevsky FK, Bonan CD, Barreto-Chaves ML, Freitas Sarkis JJ 5g2-nucleotidase activity is altered by hypo- and hyperthyroidism in platelets from adult rats. Platelets. 2005 ; 16 (1). 25-30.
9. Bergh JJ, Lin H. -Y, Lansing L., et al. Integrin ±vβ3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology. 2005 ; 146 (7). 2864-2871.
10. Mousa SA, O'Connor L., Davis FB, Davis PJ Proangiogenesis action of the thyroid hormone analog 3,5-diiodothyropropionic acid (DITPA) is initiated at the cell surface and is integrin mediated. Endocrinology. 2006 ; 147 (4). 1602-1607.
11. Mousa SA, Davis FB, Mohamed S., Davis PJ, Feng X. Pro-angiogenesis action of thyroid hormone and analogs in a three-dimensional in vitro microvascular endothelial sprouting model. Int Angiol. 2006 ; 25 (4). 407-413.
12. Davis FB, Mousa SA, O'Connor L., et al. Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface. Circ Res. 2004 ; 94 (11). 1500-1506.
13. Mousa SA, O'Connor LJ, Bergh JJ, Davis FB, Scanlan TS, Davis PJ The proangiogenic action of thyroid hormone analogue GC-1 is initiated at an integrin. J Cardiovasc Pharmacol. 2005 ; 46 (3). 356-360.
14. El Eter E., Rabee H., Alkayali A., Mousa SA Role of thyroid hormone analogs in angiogenesis and the development of collaterals in rabbit hind limb ischemia model. J Thromb Thrombolysis. 2007 ; 5 (suppl 1). 375.
15. Bennett JS, Chan C., Vilaire G., Mousa SA, DeGrado WF Agonist-activated alphavbeta3 on platelets and lymphocytes binds to the matrix protein osteopontin. J Biol Chem. 1997 ; 272 (13). 8137-8140.
16. Litvinov RI, Vilaire G., Shuman H., Bennett JS, Weisel JW Quantitative analysis of platelet alpha v beta 3 binding to osteopontin using laser tweezers. J Biol Chem. 2003 ; 278 (51). 51285-51290.
17. McCarty OJ, Zhao Y., Andrew N., et al. Evaluation of the role of platelet integrins in fibronectin-dependent spreading and adhesion. J Thromb Haemost. 2004 ; 2 (10). 1823-1833.
18. Shattil SJ, Newman PJ Integrins: dynamic scaffolds for adhesion and signaling in platelets. Blood. 2004 ; 104 (6). 1606-1615.
19. Morkin E., Ladenson P., Goldman S., Adamson C. Thyroid hormone analogs for treatment of hypercholesterolemia and heart failure: past, present and future prospects. J Mol Cell Cardiol. 2004 ; 37 (6). 1137-1146.
20. Mousa SA, Ahmad S. Platelet GPIIb/IIIa antagonist, XV459, in heparin-induced thrombocytopenia. Am J Hematol. 2007 ; 82 (4). 276-278.
21. McGlasson DL, Fritsma GA Comparison of four laboratory methods to assess aspirin sensitivity. Blood Coagul Fibrinolysis. 2008 ; 19 (2). 120-123.
22. Keevil JG, Osman HE, Reed JD, Folts JD Grape juice, but not orange juice or grapefruit juice, inhibits human platelet aggregation. J Nutr. 2000 ; 130 (1). 53-56.
23. Homoncik M., Gessl A., Ferlitsch A., Jilma B., Vierhapper H. Altered platelet plug formation in hyperthyroidism and hypothyroidism. J Clin Endocrinol Metab. 2007 ; 92 (8). 3006-3012.
24. Coban E., Yazicioglu G., Ozdogan M. Platelet activation in subjects with subclinical hypothyroidism. Med Sci Monit. 2007 ; 13 (4). CR211 - CR214.
25. Masunaga R., Nagasaka A., Nakai A., et al. Alteration of platelet aggregation in patients with thyroid disorders. Metabolism. 1997 ; 46 (10). 1128-1131.
26. Edson JR, Fecher DR, Doe RP Low platelet adhesiveness and other hemostatic abnormalities in hypothyroidism. Ann Intern Med. 1975 ; 82 (3). 342-346.
27. Cody V., Davis PJ, Davis FB Molecular modeling of the thyroid hormone interactions with alpha v beta 3 integrin. Steroids. 2007 ; 72 (2). 165-170.
28. Green JM, Zhelesnyak A., Chung J., et al. Role of cholesterol in formation and function of a signaling complex involving alphavbeta3, integrin-associated protein (CD47), and heterotrimeric G proteins. J Cell Biol. 1999 ; 146 (3). 673-682.